Clorox
CLX
Market cap $15.4B

126.54 USD

-1.30

1.02%

At close Jul 11, 4:00 PM EDT

After hours

126.54

+0.00

0.00%

1 day

-1.02%

5 days

1.86%

1 month

0.22%

3 months

-10.53%

6 months

-19.64%

Year to date

-21.81%

1 year

-6.16%

5 years

-43.94%

10 years

16.44%

About: Since its start more than 100 years ago, Clorox has expanded to operate in a variety of consumer products categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. More than 80% of Clorox's sales come from its home turf.

Employees: 7,400

Consumer Staples Household & Personal Products

0

Funds holding %

of 7,312 funds

0

Analysts bullish %

of 7 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

78% more call options, than puts

Call options by funds: $262M | Put options by funds: $147M

1% more repeat investments, than reductions

Existing positions increased: 410 | Existing positions reduced: 407

0.38% less ownership

Funds ownership: 80.76% [Q4 2024] → 80.37% (-0.38%) [Q1 2025]

4% less funds holding

Funds holding: 1,200 [Q4 2024] → 1,155 (-45) [Q1 2025]

12% less capital invested

Capital invested by funds: $16.5B [Q4 2024] → $14.6B (-$1.97B) [Q1 2025]

17% less first-time investments, than exits

New positions opened: 110 | Existing positions closed: 132

60% less funds holding in top 10

Funds holding in top 10: 5 [Q4 2024] → 2 (-3) [Q1 2025]

See Fund Rankings

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$129

2%

upside

Avg. target

$144

14%

upside

High target

$154

22%

upside

7 analyst ratings

1 positive

14%

5 neutral

71%

1 negative

14%

Wells Fargo Chris Carey	7%upside $135	Equal-Weight Maintained	9 Jul 2025
Jefferies Kaumil Gajrawala	15%upside $145	Buy Maintained	26 Jun 2025
Barclays Lauren Lieberman	2%upside $129	Underweight Maintained	7 May 2025
Morgan Stanley Dara Mohsenian	19%upside $150	Equal-Weight Maintained	6 May 2025
JP Morgan Andrea Teixeira	14%upside $144	Neutral Maintained	6 May 2025

See Analyst Rankings

Financial journalist opinion

Based on 15 articles about CLX published over the past 30 days

Clorox Announces July 31 Webcast of Fourth-Quarter and Fiscal Year 2025 Results

OAKLAND, Calif. , July 10, 2025 /PRNewswire/ -- The Clorox Company (NYSE: CLX) will issue its fourth-quarter and fiscal year 2025 results on July 31, 2025.

Clorox Announces July 31 Webcast of Fourth-Quarter and Fiscal Year 2025 Results

Zacks Investment Research

ADRNY or CLX: Which Is the Better Value Stock Right Now?

Investors with an interest in Consumer Products - Staples stocks have likely encountered both Ahold NV (ADRNY) and Clorox (CLX). But which of these two stocks offers value investors a better bang for their buck right now?

ADRNY or CLX: Which Is the Better Value Stock Right Now?

Clorox Among 14 Dividend Growth Companies Announcing Annual Increases In July

I provide July dividend increase predictions for 14 long-term dividend growth companies, analyzing recent results and forward yields for each. Clorox is expected to announce a modest dividend increase of around 2% due to its high payout ratio, despite improving earnings outlook. Several companies, like Cintas and McKesson, are set for double-digit dividend growth, while others like Stanley Black & Decker are likely to announce minimal increases.

Clorox Among 14 Dividend Growth Companies Announcing Annual Increases In July

Clorox: The Comeback May Be Starting

Clorox's Q3 showed weak revenue and EPS, but margin improvements signal management is focused on efficiency and profitability. FY2025 guidance implies a strong Q4 rebound, with both revenue and EPS expected to return to positive growth territory. The stock's P/S ratio is near multi-year lows, suggesting undervaluation relative to historical levels and offering a potential opportunity.

Clorox: The Comeback May Be Starting

Best Dividend Aristocrats For July 2025

Dividend Aristocrats have underperformed the S&P 500 in 2025, with NOBL up 1.77% versus SPY's 5.55% year-to-date gain. Dividend growth remains healthy, with 44 out of 69 Aristocrats already raising payouts in 2025 and an average growth rate of 4.86%. I identified 21 Aristocrats as both potentially undervalued and offering a projected long-term annualized return of at least 10%.

Best Dividend Aristocrats For July 2025

Zacks Investment Research

Is Clorox's International Expansion Key to Its Long-Term Success?

CLX bets on global growth as it expands in Latin America and Asia, aiming to offset slowing U.S. sales with long-term international gains.

Is Clorox's International Expansion Key to Its Long-Term Success?

Zacks Investment Research

Is the Options Market Predicting a Spike in Clorox Stock?

Investors need to pay close attention to CLX stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in Clorox Stock?

24/7 Wall Street

The 4 Dividend Aristocrats Warren Buffett Would Buy Next

Warren Buffett is well known for favoring companies with a strong dividend track record.

The 4 Dividend Aristocrats Warren Buffett Would Buy Next

Zacks Investment Research

ADRNY vs. CLX: Which Stock Is the Better Value Option?

Investors with an interest in Consumer Products - Staples stocks have likely encountered both Ahold NV (ADRNY) and Clorox (CLX). But which of these two stocks presents investors with the better value opportunity right now?

ADRNY vs. CLX: Which Stock Is the Better Value Option?

69 June Aristocrats: 1 To Buy

Five of the ten lowest-priced S&P 500 Dividend Aristocrats are currently attractive buys, offering high yields and fair valuations for income investors. Analyst forecasts suggest potential net gains of 15.65% to 36.53% for the top ten Aristocrat Dogs by June 2026, with average risk below the market. Fifteen Aristocrats show negative free cash flow margins, signaling caution—dividends may not be sustainable for these cash-poor stocks.

69 June Aristocrats: 1 To Buy

See News Rankings

Charts implemented using Lightweight Charts™